Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessment of therapy response in malignant tumours with 18F-fluorothymidine.

× No keyword cloud information.

25 in total

1. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors: P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506

2. Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.

Authors: Betty S Pio; Cecilia K Park; Richard Pietras; Wei-Ann Hsueh; Nagichettiar Satyamurthy; Mark D Pegram; Johannes Czernin; Michael E Phelps; Daniel H S Silverman
Journal: Mol Imaging Biol Date: 2006 Jan-Feb Impact factor: 3.488

3. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.

Authors: Rakesh Kumar; Yan Xiu; Scott Potenta; Ayse Mavi; Hongming Zhuang; Jian Q Yu; Thiruvekatasamy Dhurairaj; Simin Dadparvar; Abass Alavi
Journal: J Nucl Med Date: 2004-11 Impact factor: 10.057

4. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

Authors: R L Wahl; K Zasadny; M Helvie; G D Hutchins; B Weber; R Cody
Journal: J Clin Oncol Date: 1993-11 Impact factor: 44.544

5. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy.

Authors: K Higashi; A C Clavo; R L Wahl
Journal: J Nucl Med Date: 1993-05 Impact factor: 10.057

6. Early changes in [18F]FLT uptake after chemotherapy: an experimental study.

Authors: Helmut Dittmann; Bernhard Matthias Dohmen; Rainer Kehlbach; Gabi Bartusek; Maren Pritzkow; Mario Sarbia; Roland Bares
Journal: Eur J Nucl Med Mol Imaging Date: 2002-09-06 Impact factor: 9.236

7. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines.

Authors: Ulrike Seitz; Martin Wagner; Bernd Neumaier; Edgar Wawra; Gerhard Glatting; Gerhard Leder; Roland M Schmid; Sven N Reske
Journal: Eur J Nucl Med Mol Imaging Date: 2002-06-04 Impact factor: 9.236

8. 3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.

Authors: Andreas K Buck; Holger Schirrmeister; Martin Hetzel; Mareike Von Der Heide; Gisela Halter; Gerhard Glatting; Torsten Mattfeldt; Florian Liewald; Sven N Reske; Bernd Neumaier
Journal: Cancer Res Date: 2002-06-15 Impact factor: 12.701

9. The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels.

Authors: Henryk Barthel; Meg Perumal; John Latigo; Qimin He; Frank Brady; Sajinder K Luthra; Pat M Price; Eric O Aboagye
Journal: Eur J Nucl Med Mol Imaging Date: 2004-09-04 Impact factor: 9.236

10. Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

Authors: Laura Kenny; R Charles Coombes; David M Vigushin; Adil Al-Nahhas; Sami Shousha; Eric O Aboagye
Journal: Eur J Nucl Med Mol Imaging Date: 2007-03-02 Impact factor: 9.236